⋮
0
0
European Medicines Agency (EMA) Accepts Otsuka’s Marketing Authorisation Application (MAA) for Tolvaptan, an Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Showing live article 221 of 7771 in channel 19680790
Article Details:
Author:
Language: Japanese
Channel Number: 19680790
Article Number: 221
Date: December 26, 2013, 11:25 pm
URL: http://www.qlifepro.com/press/20131227-16-5085/otsuka-pharmaceutical-30/
GUID: http://www.qlifepro.com/press/?p=5085
←
$
..going to article 221
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL